“They wanted to right a wrong,” Daniel C. Oliverio, lawyer to one of the undercover whistleblowers, said of the five former employees in the case.
And that they did - by exposing the second biggest pharmaceutical scam in history, resulting in a $2.2 billion civil and criminal settlement by Johnson & Johnson surrounding its off-label marketing of anti-psychotic drug, Risperdal.
But "righting wrongs" also has its rewards. The breakdown of the $2.2 billion settlement is as follows: about $1.27 billion will go to settle civil claims against the company. From this, the whistelblowers will collectively receive 168M. The remaining $900,000 in the $2.2B will settle the criminal case.